1. Home
  2. KYN vs AMRX Comparison

KYN vs AMRX Comparison

Compare KYN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYN
  • AMRX
  • Stock Information
  • Founded
  • KYN 2004
  • AMRX 2002
  • Country
  • KYN United States
  • AMRX United States
  • Employees
  • KYN N/A
  • AMRX N/A
  • Industry
  • KYN Finance/Investors Services
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KYN Finance
  • AMRX Health Care
  • Exchange
  • KYN Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • KYN 2.2B
  • AMRX 2.4B
  • IPO Year
  • KYN N/A
  • AMRX N/A
  • Fundamental
  • Price
  • KYN $12.90
  • AMRX $8.28
  • Analyst Decision
  • KYN
  • AMRX Strong Buy
  • Analyst Count
  • KYN 0
  • AMRX 5
  • Target Price
  • KYN N/A
  • AMRX $10.80
  • AVG Volume (30 Days)
  • KYN 561.5K
  • AMRX 1.9M
  • Earning Date
  • KYN 01-01-0001
  • AMRX 05-02-2025
  • Dividend Yield
  • KYN 8.99%
  • AMRX N/A
  • EPS Growth
  • KYN N/A
  • AMRX N/A
  • EPS
  • KYN 0.71
  • AMRX N/A
  • Revenue
  • KYN N/A
  • AMRX $2,793,957,000.00
  • Revenue This Year
  • KYN N/A
  • AMRX $9.77
  • Revenue Next Year
  • KYN N/A
  • AMRX $4.99
  • P/E Ratio
  • KYN $13.79
  • AMRX N/A
  • Revenue Growth
  • KYN N/A
  • AMRX 16.73
  • 52 Week Low
  • KYN $7.84
  • AMRX $5.18
  • 52 Week High
  • KYN $9.88
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • KYN 56.85
  • AMRX 43.36
  • Support Level
  • KYN $11.89
  • AMRX $8.18
  • Resistance Level
  • KYN $13.05
  • AMRX $8.95
  • Average True Range (ATR)
  • KYN 0.21
  • AMRX 0.30
  • MACD
  • KYN 0.07
  • AMRX -0.08
  • Stochastic Oscillator
  • KYN 85.44
  • AMRX 10.87

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: